Mount Sinai scientists unlock secrets of key SARS-CoV-2 enzyme

By The Science Advisory Board staff writers

September 12, 2022 -- Mount Sinai researchers have produced a high-resolution crystal structure of an enzyme that is essential to the survival of SARS-CoV-2. The finding could lead to more antivirals to combat current and future coronaviruses, they added.

The scientists developed three crystal structures of coronavirus nonstructural protein 14, which contains the RNA methyltransferase domain (Nat Struct Mol Bio, September 8, 2022). They used fusion-assisted crystallization, which fuses the enzyme with another small protein that helps it to crystalize.

In terms of developing antivirals, each crystal structure had different cofactors, and the researchers identified the best scaffold for the design of antivirals that would inhibit RNA methyltransferase activity. The antiviral takes the place of the natural cofactor S-adenosylmethionine and prevents the methyltransferase chemistry from occurring. Doing so means the coronavirus is unable to survive.

The research paves the way for designing more broad-spectrum antivirals that include small molecule inhibitors.

Antiviral therapy blocks COVID-19 transmission in hamsters: study
Researchers at Gladstone Institutes have shown that a new single-dose intranasal, antiviral treatment for SARS-CoV-2 infection decreases viral shedding...
Key vulnerability discovered across all major SARS-CoV-2 variants
Researchers at the University of British Columbia have discovered a “weak spot” across all major variants of the SARS-CoV-2 virus, including the recently...
New antibody neutralizes all known SARS-CoV-2 variants: study
An antibody developed at Boston Children’s Hospital neutralizes all known SARS-CoV-2 variants, including omicron subvariants, which may inform the design...
Antibodies create broad SARS immune response: study
Scientists from Scripps Research have discovered certain antibodies are capable of immunity against many different SARS-CoV-2 variants, as well as other...
CRISPR-based study identifies lung proteins that promote, protect against SARS-CoV-2 infections
A study led by University of California, Berkeley researchers has identified specific proteins within the human body that can either promote SARS-CoV-2...

Copyright © 2022

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter